Organization

Field Name

ID

Required

KCR

Grade Post Therapy Clin (yc)

30141

yes 

SEER

Grade Post Therapy Clin (yc)

1068

yes 

Note 1 Leave Grade Post Therapy Clin (yc) blank when

  • No neoadjuvant therapy
  • Clinical or pathological case only
  • Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
  • There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological

Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.

Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.

Note 4 Priority order for codes

  • Invasive cancers codes 1-3 take priority over A-D.
  • In situ cancers codes L, M, H take priority over A-D

Note 5 Scarff-Bloom-Richardson (SBR) score is used for grade. SBR is also referred to as Bloom-Richardson, Nottingham, Nottingham modification of Bloom-Richardson score, Nottingham modification, Nottingham-Tenovus grade, or Nottingham score.

Note 6 All invasive breast carcinomas should be assigned a histologic grade. The Nottingham combined histologic grade (Nottingham modification of the SBR grading system) is recommended. The grade for a tumor is determined by assessing morphologic features (tubule formation, nuclear pleomorphism, and mitotic count), assigning a value from 1 (favorable) to 3 (unfavorable) for each feature, and totaling the scores for all three categories. A combined score of 3–5 points is designated as grade 1; a combined score of 6–7 points is grade 2; a combined score of 8–9 points is grade 3.

  • Do not calculate the score unless all three components are available

Note 7 Code 9 (unknown) when

  • Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
  • Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
  • Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available

Note 8 If you are assigning an AJCC 8th edition stage group

  • Grade is required to assign stage group
  • Codes A-D are treated as an unknown grade when assigning AJCC stage group
  • An unknown grade may result in an unknown stage group

Code

Description

1

G1: Low combined histologic grade (favorable), SBR score of 3-5 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 1

2

G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 2

3

G3: High combined histologic grade (unfavorable); SBR score of 8-9 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 3

L

Nuclear Grade I (Low) (in situ only)

M

Nuclear Grade II (interMediate) (in situ only)

H

Nuclear Grade III (High) (in situ only)

A

Well differentiated

B

Moderately differentiated

C

Poorly differentiated

D

Undifferentiated, anaplastic

9

Grade cannot be assessed (GX); Unknown

<BLANK>

See Note 1